Author Information
John D. Parker is a distinguished researcher affiliated with the Department of Pharmacology and Toxicology at the University of Toronto, Ontario, Canada. His expertise lies predominantly in the field of pharmacology, with a significant focus on cardiovascular research and heart failure. His work frequently explores advanced therapeutic interventions and physiological mechanisms, contributing significantly to clinical and experimental medicine.Research Contributions
John D. Parker's research contributions span several key areas in cardiovascular medicine, including autonomic regulation therapy using vagal nerve stimulation, renal hemodynamics in heart failure, and the effects of different pharmacological interventions on heart function. His work in understanding the efficacy and safety of novel treatments, such as the soluble guanylate cyclase stimulator Praliciguat, is particularly noteworthy. Parker has also engaged in comparative studies of therapeutic responses and explored the physiological implications of factors like sleep apnea and endothelial function in cardiovascular health.Aliases
Throughout his academic career, John D. Parker has been published under various aliases, including John D. Parker, John D Parker, J. David Parker, J Parker, and several others. These variations are common in academic publishing and reflect different naming conventions across journals and publications.Publication and Citation Metrics
| Metric |
Value |
| Total Publications |
288 |
| Total Citations |
10,582 |
| H-index |
53 |
